Cancer diagnostics News and Research

RSS

Study: Metformin may not improve survival rates after breast cancer

Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.

10 May 2013

New study examines treatment delays in black women with breast cancer

Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days - a time delay associated with increased deaths from the disease, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center.

8 May 2013

Shore Medical Center inks affiliation agreement with The Cancer Institute of New Jersey

Shore Medical Center is pleased to announce it has entered into an affiliation agreement with The Cancer Institute of New Jersey - the state's only National Cancer Institute-designated Comprehensive Cancer Center.

3 May 2013

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Cancer Genetics, Inc., a leader in oncology-focused personalized medicine, has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.

3 May 2013

Research roundup: Young women and delays in breast cancer diagnosis

Adolescents and young adults (ages 15-39) make up 5 and 6 percent of all breast cancer cases in the United States and have the lowest five-year survival rates.

30 Apr 2013

Study shows intraventricular chemotherapy increases overall survival in LMC patients

Lung cancer is one of the most common primary cancers that cause leptomeningeal carcinomatosis (LMC), when cancer spreads to the membranes surrounding the spinal cord and brain. Cases of LMC have increased because of the improved survival of lung cancer patients with the help of new advances in treatment.

23 Apr 2013

Viewpoints: 9 'brilliant legal minds' wrestle with tough biological questions in gene case; Drug overdoses take surprising toll in Calif.; VA case raises privacy questions

When the Supreme Court took up the question Monday of whether genes could be patented, the justices were clearly concerned about preserving innovation in medicine and biotechnology. But the issue presented by Myriad Genetics' patents on the BRCA genes cuts both ways, leading to a potential split among the justices (Jon Healey, 4/15).

17 Apr 2013

Study reports 41% reduction in colorectal mortality rates for African Americans

A study analyzing the impact of the Delaware Cancer Consortium, the state's cancer control program, reports a 41 percent reduction in colorectal mortality rates for African Americans.

16 Apr 2013

New breast imaging programs effective in diagnosing palpable breast masses in Ugandan women

Radiologists are a step closer to implementing a program in an underserved region of Uganda for diagnosing and treating women with palpable breast masses.

15 Apr 2013

Study: Average-risk screening ADR is higher than current guidelines suggest for men and women

Researchers at Mayo Clinic in Jacksonville, Florida, report in a new study that average-risk screening adenoma detection rates (ADR) are significantly higher than current guidelines suggest for both men and women.

12 Apr 2013

QOPI Certification Program certifies MD Anderson Cancer Center Orlando

MD Anderson Cancer Center Orlando, known for inspiring hope through extraordinary care in Central Florida has now received a prestigious national certification from the Quality Oncology Practice Initiative (QOPI) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO). The QOPI Certification Program (QCP) certifies oncology practices that meet the highest quality standards for cancer care.

11 Apr 2013

Researchers evaluate Pexa-Vec to slow progression of liver cancer

As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.

10 Apr 2013

OTraces completes Phase II testing for blood test that detects breast cancer

OTraces, Inc., a Maryland-based biotech company developing blood tests for cancer diagnosis, announces completion of Phase II testing for a blood test that screens women for breast cancer.

10 Apr 2013

CvergenX to develop radiosensitivity test to better radiation therapy decisions for patients with cancer

A molecular signature index technology that can lead to better radiation therapy decisions for patients with cancer is being developed into a reliable radiosensitivity test by CvergenX, Inc., an advanced cancer diagnostics company.

10 Apr 2013

Study finds alcohol consumption has no impact on mortality of breast cancer survivors

Although previous research has linked alcohol consumption to an increased risk of developing breast cancer, a new study has found that drinking before and after diagnosis does not impact survival from the disease.

9 Apr 2013

Nano-sized EVs play role in cancer growth and survival

The recent discovery of circulating "nano-sized extracellular vesicles" (EVs) carrying proteins and nucleic acids derived from brain tumors may lead to exciting new avenues for brain cancer diagnosis, monitoring, and treatment, according to a special article in the April issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

9 Apr 2013

Anirban Maitra to lead pancreatic cancer research at UT MD Anderson Cancer Center

Anirban Maitra, M.B.B.S., a pre-eminent expert in the genetics of pancreatic cancer and the development of targeted therapies for the disease, will lead research at a new center at The University of Texas M.D. Anderson Cancer Center devoted to this highly lethal cancer.

5 Apr 2013

Cancer diagnostics News and Research

Study: Metformin may not improve survival rates after breast cancer

New study examines treatment delays in black women with breast cancer

Shore Medical Center inks affiliation agreement with The Cancer Institute of New Jersey

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Research roundup: Young women and delays in breast cancer diagnosis

Study shows intraventricular chemotherapy increases overall survival in LMC patients

Viewpoints: 9 'brilliant legal minds' wrestle with tough biological questions in gene case; Drug overdoses take surprising toll in Calif.; VA case raises privacy questions

Study reports 41% reduction in colorectal mortality rates for African Americans

New breast imaging programs effective in diagnosing palpable breast masses in Ugandan women

Study: Average-risk screening ADR is higher than current guidelines suggest for men and women

QOPI Certification Program certifies MD Anderson Cancer Center Orlando

Researchers evaluate Pexa-Vec to slow progression of liver cancer

OTraces completes Phase II testing for blood test that detects breast cancer

CvergenX to develop radiosensitivity test to better radiation therapy decisions for patients with cancer

Study finds alcohol consumption has no impact on mortality of breast cancer survivors

Nano-sized EVs play role in cancer growth and survival

Anirban Maitra to lead pancreatic cancer research at UT MD Anderson Cancer Center

GWCI receives support from Susan G. Komen for the Cure to care for D.C.-area breast cancer survivors

UAB School of Nursing offers health care services in rural communities

Researchers validate metabolomic analysis as new diagnostic method for pancreatic cancer

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News